LLY
977.6
-2.15%↓
JNJ
242.96
-0.06%↓
ABBV
225.37
-0.98%↓
NVS
154.16
-0.82%↓
AZN
191.88
-0.58%↓
LLY
977.6
-2.15%↓
JNJ
242.96
-0.06%↓
ABBV
225.37
-0.98%↓
NVS
154.16
-0.82%↓
AZN
191.88
-0.58%↓
LLY
977.6
-2.15%↓
JNJ
242.96
-0.06%↓
ABBV
225.37
-0.98%↓
NVS
154.16
-0.82%↓
AZN
191.88
-0.58%↓
LLY
977.6
-2.15%↓
JNJ
242.96
-0.06%↓
ABBV
225.37
-0.98%↓
NVS
154.16
-0.82%↓
AZN
191.88
-0.58%↓
LLY
977.6
-2.15%↓
JNJ
242.96
-0.06%↓
ABBV
225.37
-0.98%↓
NVS
154.16
-0.82%↓
AZN
191.88
-0.58%↓
24h
Current
Min
21.49
Max
22.64
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +261.27% upside |
Next Earnings | 20 Mar 2026 |
|---|
Past performance is not a reliable indicator of future results.
9 Oct 2025, 14:24 UTC
Neurogene Shares Rise After NGN-401 Discussions With FDA
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 83.2 USD 261.27%
High 200 USD
Low 46 USD
Based on 6 Wall Street analysts offering 12 month price targets forNeurogene Inc - Dist in the last 3 months.
By TipRanks
Strong Buy
6 ratings
6
Buy
0
Hold
0
Sell
Based on 6 analysts giving stock ratings to Neurogene Inc - Dist in the past 3 months.
$